Last reviewed · How we verify

NCT04887363

The Comparisons of Effects of Core Stability Exercise and Tai Chi on Core Muscle Performances in Elderly

Completed NA Last updated 14 May 2021
What this trial tests

NA trial testing Core exercise in Tai Ji in 71 participants. Completed in 30 June 2015.

Timeline
3 June 2013
Primary endpoint
30 June 2015
30 June 2015

Quick facts

Lead sponsorKaohsiung Medical University Chung-Ho Memorial Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment71
Start date3 June 2013
Primary completion30 June 2015
Estimated completion30 June 2015

Drugs / interventions tested

Conditions studied

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Who can join

Adults 20 to 74, any sex, with Tai Ji. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Core muscles and core stability has a key component in the postural control or balance. However, no clear evidence has been found for the positive relationship between core stability and postural control in the elderly, and the effects of core stabilizing training on postural control or balance in the elderly. The purposes of this project are to investigate the effects of core stability training program on muscle strength, muscle performance, and balance outcomes in elderly adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Core exercise

Trials testing the same drug.

Other Kaohsiung Medical University Chung-Ho Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04887363.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing